8-KItem 5.02 · Officer/Director ChangeItem 8.01 · Other EventsItem 9.01 · Financial Statements
BIO-TECHNE Corp (TECH)

BIO‑TECHNE ($TECH) filed an 8‑K on Feb 11, 2026 disclosing an Executive Employment Agreement with Steve…

Filed with the SEC on · Summarized by InvestorsBot

BIO‑TECHNE ($TECH) filed an 8‑K on Feb 11, 2026 disclosing an Executive Employment Agreement with Steve Crouse dated Feb 10, 2026 (Exhibit 10.1). Investors should review the exhibit for role/compensation details. 📝🤝 #SEC #ExecHire

Related press release filed as Exhibit 99.1 on Feb 11, 2026; 8‑K signed by Shane V. Bohnen (SVP, General Counsel). See the attached exhibits for full terms and material details. $TECH 🔍📄 #CorporateGovernance #Biotech

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from BIO-TECHNE Corp

Bio‑Techne Corp filed Form 8‑K (Item 8.01) on Feb 11, 2026 — a press release was attached as Exhibit 99.1.

8-K · February 11, 2026

$TECH: Dr.

8-K · February 11, 2026

BIO‑TECHNE filed an 8‑K on Feb 4, 2026 attaching a press release (Ex.

8-K · February 4, 2026

Bio-Techne ($TECH) announced a cash dividend via press release dated Feb 4, 2026.

8-K · February 4, 2026

Bio‑Techne ($TECH) issued a press release on Feb 4, 2026 reporting results for the quarter and six months…

8-K · February 4, 2026